Back to Startup Insights
Xaira Therapeutics
San Francisco Bay Area-based biotech company founded in 2024 combining therapeutics with AI intelligence.
Headquarters
San Francisco, USA
Year Founded
2024
Founders
Not specified
Country
United States
Financial Information
Funding Stage
Series A
Recent Funding
$1B
Funding By
Major Tech and Pharma Investors
Core Technology
AI-driven therapeutics
Product Type
Drug
Pipeline Stage (Very Important)
Discovery
Regulatory Status
- IND Filed: No
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Filed
Partnerships
Pharma Collaborations
Tech partnerships
Academic / Hospital Tie-ups
Stanford University
CRO/CDMO Partnerships
None
Market & Differentiation
AI-powered therapeutic development